ARCHIVES

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Ginder To direct Massey Cancer Center; UAB Receives $1 Million for Genetics Chair

August 15, 1997

Program Announcement For Clinical Research

February 29, 1980

In Brief: A Third Of Smokers Quit For Smokeout-Gallup; 77 Percent Pass Oncology Nursing Examination

November 23, 1990

Velcade Improves Survival In Relapsed Multiple Myeloma

July 29, 2005

Duke Vice Dean Cuffe Promises Complete, Independent Probe Of Work By Potti, Nevins.

July 30, 2010

Charges Against CC Probed; Most Found Invalid

March 31, 1978